Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Vetenskapsrådet
Sahlgrenska Universitetssjukhuset
BioGaia AB
University of Gothenburg
- License Information
-
More Information
Article History
Received: 2 October 2025
Accepted: 14 January 2026
First Online: 2 February 2026
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Dnr: 2019-03740) and is registered at ClinicalTrials.gov with the registration number NCT04169789.
: M. Lorentzon has received lecture fees from Amgen, Astellas, Meda, Jansen-Cilag, Medison Pharma, Gedeon Richter, UCB Pharma, and consulting fees from Amgen, UCB Pharma, Medac, Gedeon Richter, and Pharmacosmos, all outside the presented research. All other authors have no conflicts of interest.
